Reactive Airway Disease Management
Definition and Pathophysiology
- Reactive airway disease is characterized by variable and recurring symptoms, airflow obstruction, bronchial hyperresponsiveness, and underlying inflammation, involving multiple cell types including mast cells, eosinophils, neutrophils, T lymphocytes, macrophages, and epithelial cells, according to the American Academy of Allergy, Asthma, and Immunology 1
- The condition causes recurrent episodes of wheezing, breathlessness, chest tightness, and coughing, particularly at night or early morning, with widespread but variable airflow obstruction that is often reversible either spontaneously or with treatment, as stated by the American College of Chest Physicians 2
Diagnosis
- Diagnosis is based on clinical presentation, medical history, physical examination, and objective measurements of lung function, including history of variable respiratory symptoms and confirmation of variable airflow limitation through spirometry, as recommended by the American Thoracic Society 2
- Key diagnostic elements include documentation of airway hyperresponsiveness through bronchoprovocation testing when spirometry is normal, and exclusion of alternative diagnoses, according to the National Asthma Education and Prevention Program 2
Management Approach
- The American College of Allergy, Asthma, and Immunology recommends a stepwise treatment approach, starting with short-acting beta-agonists as needed for mild intermittent disease, and progressing to low-dose inhaled corticosteroids as preferred controller for mild persistent disease, with alternatives including leukotriene modifiers, theophylline, cromolyn, or nedocromil 4
- For moderate persistent disease, the American Academy of Allergy, Asthma, and Immunology suggests low-to-medium dose inhaled corticosteroids plus long-acting beta-agonist, with alternatives including medium-dose inhaled corticosteroids alone or low-to-medium dose inhaled corticosteroids plus either leukotriene modifier or theophylline 4
- The European Respiratory Society recommends removal of exposure to the causative agent as the best option for occupational asthma, with reduction as the second-best option if removal is not possible, and notes that respirators provide limited value in protection 3
Special Situations
- The American College of Sports Medicine recommends pretreatment with short-acting beta-agonists, leukotriene receptor antagonists, cromolyn, or nedocromil for exercise-induced bronchoconstriction, and advises against frequent use of long-acting beta-agonists for pretreatment, according to the American Academy of Allergy, Asthma, and Immunology 1
- The American College of Obstetricians and Gynecologists recommends monitoring asthma control during all prenatal visits, maintaining treatment as it is safer than having poorly controlled asthma, and using albuterol as the preferred short-acting beta-agonist and budesonide as the preferred inhaled corticosteroid during pregnancy, as stated by the National Asthma Education and Prevention Program 1
Follow-up and Monitoring
- The British Thoracic Society recommends regular monitoring of symptoms and peak expiratory flow, providing patients with a peak expiratory flow meter and self-management plan, and scheduling follow-up within 24-48 hours after an acute exacerbation, according to the National Institute for Health and Care Excellence 5
- The American Academy of Allergy, Asthma, and Immunology suggests modifying treatment according to level of control, and considering referral to an asthma specialist for atypical presentations, difficult differential diagnoses, or when additional testing is indicated, as recommended by the American College of Allergy, Asthma, and Immunology 4